Ambulatory Laparoscopic Cholecystectomy. A Cohort Study of 1600 Consecutive Cases

• Published in: Cirugia española (English ed.) Vol. 91; no. 3; pp. 156 - 162
• Main Authors: Planells Roig, Manuel, Garcia Espinosa, Rafael, Cervera Delgado, María, Navarro Vicente, Francisco, Carrau Giner, Miguel, Sanahuja Santafé, Ángel, Arnal Bertomeu, Consuelo
• Format: Journal Article
• Language: English
• Published: Elsevier España, S.L.U 01-03-2013
• Subjects: Ambulatory laparoscopic cholecystectomy; Ambulatory surgery; Cirugía mayor ambulatoria; Colecistectomía laparoscópica ambulatoria; Colecistectomía laparoscópica coste-efectiva; Cost-effective laparoscopic cholecystectomy; Surgery; Colecistectomía laparoscópica ambulatoria; Ambulatory surgery; Ambulatory laparoscopic cholecystectomy; Colecistectomía laparoscópica coste-efectiva; Cost-effective laparoscopic cholecystectomy; Cirugía mayor ambulatoria
• ISSN: 2173-5077; 2173-5077
• DOI: 10.1016/j.cireng.2013.07.019

Abstract Objective A descriptive analysis of day-case laparoscopic cholecystectomy (ALC) in a cohort of 1600 consecutive patients performed in Instituto de Cirugía y Aparato Digestivo (ICAD), Clínica Quirón de Valencia in the period 1997–2010. Patients and methods Prospective observational study of 1601 consecutive patients undergoing elective laparoscopic cholecystectomy (LC) provided by the regional health service and private health companies. Main measures Conversion rate, non-planned admissions, readmissions, surgery duration and demographics. Results ALC was successfully performed in 80.8% of cases. LC with over-night (ON) stay accounted for 13.4% of patients. Admission was necessary in 4.6%. Mortality was 0.13%, 0.08 in ALC and 0.5% in ON LC. Readmissions occurred in 2.1%, 1.6% in ALC group, 5.4% in ON stay and 4.2% in admission group. Conclusions ALC is a reliable and safe procedure. Minimization of admission rates is the key for cost-effective optimization in the management of cholelithiasis. ALC should be considered as the reference standard in gallbladder stone disease treatment.